Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,023 JPY
Change Today -19.00 / -1.82%
Volume 46.2K
3079 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

dvx inc (3079) Snapshot

Open
¥1,050
Previous Close
¥1,042
Day High
¥1,075
Day Low
¥1,019
52 Week High
07/27/15 - ¥1,480
52 Week Low
10/14/14 - ¥978.16
Market Cap
11.5B
Average Volume 10 Days
45.5K
EPS TTM
¥107.97
Shares Outstanding
11.3M
EX-Date
03/29/16
P/E TM
9.5x
Dividend
¥23.00
Dividend Yield
1.76%
Current Stock Chart for DVX INC (3079)

Related News

No related news articles were found.

dvx inc (3079) Related Businessweek News

No Related Businessweek News Found

dvx inc (3079) Details

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. It sells arrhythmia-related products, such as pacemakers, ICDs, electrode catheters, and ablation catheters. The company also offers ischemia-related products comprising ACIST CVi contrast delivery systems; excimer laser systems; RADPAD that reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK, which reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP that reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; Lapis Blue; Resolution/Resolution SD; and Wonder Belt. In addition, DVx Inc. is involved in the research and development of medical devices and related peripheral devices; internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. The company delivers products through its sales agents. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.

234 Employees
Last Reported Date: 06/29/15
Founded in 1986

dvx inc (3079) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dvx inc (3079) Key Developments

DVx Inc. Reports Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for Six Months Ending September 30, 2015 and Year Ending March 31, 2016

DVx Inc. reported earnings results for the first quarter ended June 30, 2015. Profit for the first quarter ended June 30, 2015 was JPY 520 million or JPY 46.17 per share, compared to JPY 222 million, or JPY 19.77 per share, for the same quarter ended June 30, 2014. Net sales for the first quarter ended June 30, 2015 were JPY 7.34 billion, compared to JPY 7.09 billion for the same quarter ended June 30, 2014. Operating income for the first quarter ended June 30, 2015 was JPY 280 million, compared to JPY 348 million for the same quarter ended June 30, 2014. Ordinary income for the first quarter ended June 30, 2015 was JPY 285 million, compared to JPY 348 million for the same quarter ended June 30, 2014. For the six months ending September 30, 2015, the company expects profit to be JPY 750 million, earnings per share to be JPY 66.52, net sales to be JPY 15.73 billion and operating income to be JPY 698 million. For the year ending March 31, 2016, the company expects net sales to be JPY 31.59 billion, operating income to be JPY 1.53 billion, profit to be JPY 1.29 billion and earnings per share to be JPY 114.39.

DVx Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 2015; Provides Earnings Guidance for the First Half Ending September 2015 and Full Year Ending March 31, 2016

DVx Inc. reported consolidated earnings results for the first quarter ended June 2015. For the quarter, the company reported net sales of JPY 7,338 million against JPY 7,086 million a year ago. Operating income was JPY 280 million against JPY 348 million a year ago. Ordinary income was JPY 285 million against JPY 348 million a year ago. Net income was JPY 520 million was JPY against JPY 222 million a year ago. Net income per share was JPY 46.17 against JPY 19.77 a year ago. The company provided earnings guidance for the first half ending September 2015 and full year ending March 31, 2016. For the first half, the company expects net sales of JPY 15,734 million, operating income of JPY 698 million, ordinary income of JPY 698 million and net income of JPY 750 million or JPY 66.52 per share. For the full year, the company expects net sales of JPY 31,589 million, operating income of JPY 1,530 million, ordinary income of JPY 1,530 million and net income of JPY 1,289 million or JPY 114.39 per share.

DVx Inc. Announces Dividend for the Year Ended March 31, 2015, Payable on June 29, 2015; Provides Dividend Guidance for the Year Ending March 2016; Reports Earnings Results for the Year Ended March 31, 2015; Provides Earnings Guidance for the Six Months to September 2015 and Full Year Ending March 2016

DVx Inc. announced a dividend of JPY 18.00 per share for the year ended March 31, 2015. This dividend is payable on June 29, 2015. The company paid a dividend of JPY 30.00 per share for the same period a year ago. The company provided dividend guidance for the year ending March 2016. For the year, The company expects to pay a dividend of JPY 18.00 per share. The company reported earnings results for the year ended March 31, 2015. For the year, the company reported net sales were JPY 28,647 million compared to JP 26,420 million a year ago. Operating income was JPY 1,429 million compared to JP 1,297 million a year ago. Ordinary income was JPY 1,458 million compared to JP 1,310 million a year ago. Net income was JPY 919 million or JPY 81.57 per share compared to JP 788 million or JPY 69.92 per share a year ago. Cash flows from operating activities were JPY 515 million compared to JP 283 million a year ago. The company provided earnings guidance for the six months to September 2015 and full year ending March 2016. For the six months to September 2015, the company expects net income of JPY 453 million or JPY 40.24 per share, ordinary income of JPY 698 million, operating income of JPY 698 million on net sales of JPY 15,734 million. For the year ending March 2016, the company expects net income of JPY 993 million or JPY 88.11 per share, ordinary income of JPY 1,530 million, operating income of JPY 1,530 million on net sales of JPY 31,589 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3079:JP ¥1,023.00 JPY -19.00

3079 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Don Quijote Holdings Co Ltd ¥4,210 JPY -150.00
View Industry Companies
 

Industry Analysis

3079

Industry Average

Valuation 3079 Industry Range
Price/Earnings 9.7x
Price/Sales 0.4x
Price/Book 2.2x
Price/Cash Flow 9.0x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DVX INC, please visit www.dvx.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.